The SARS-CoV-2 antibody landscape is lower in magnitude for structural proteins, diversified for accessory proteins and stable long-term in children
Asmaa Hachim, Haogao Gu, Otared Kavian, Mike YW Kwan, Wai-hung Chan, Yat Sun Yau, Susan S Chiu, Owen TY Tsang, David SC Hui, Fionn Ma, View ORCID ProfileEric HY Lau, Samuel MS Cheng, Leo LM Poon, JS Malik Peiris, Sophie A Valkenburg, Niloufar Kavian
doi: https://doi.org/10.1101/2021.01.03.21249180
Asmaa Hachim
1HKU-Pasteur Research Pole, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China
Haogao Gu
2Division of Public Health Laboratory Sciences, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China
Otared Kavian
3Department of Mathematics, Université de Versailles Saint-Quentin, Versailles, France
Mike YW Kwan
4Department of Paediatric and Adolescent Medicine, Princess Margaret Hospital, Hospital Authority of Hong Kong, Special Administrative Region of Hong Kong, China
Wai-hung Chan
5Department of Paediatrics, Queen Elizabeth Hospital, Hospital Authority of Hong Kong, Special Administrative Region of Hong Kong, China
Yat Sun Yau
5Department of Paediatrics, Queen Elizabeth Hospital, Hospital Authority of Hong Kong, Special Administrative Region of Hong Kong, China
Susan S Chiu
6Department of Paediatric and Adolescent Medicine, The University of Hong Kong and Queen Mary Hospital, Hospital Authority of Hong Kong, Special Administrative Region of Hong Kong, China
Owen TY Tsang
7Infectious Diseases Centre, Princess Margaret Hospital, Hospital Authority of Hong Kong, Special Administrative Region of Hong Kong, China
David SC Hui
8Department of Medicine and Therapeutics, Prince of Wales Hospital, Chinese University of Hong Kong, Hong Kong SAR, China
Fionn Ma
1HKU-Pasteur Research Pole, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China
Eric HY Lau
9WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China
Samuel MS Cheng
2Division of Public Health Laboratory Sciences, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China
Leo LM Poon
1HKU-Pasteur Research Pole, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China
2Division of Public Health Laboratory Sciences, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China
JS Malik Peiris
1HKU-Pasteur Research Pole, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China
2Division of Public Health Laboratory Sciences, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China
Sophie A Valkenburg
1HKU-Pasteur Research Pole, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China
Niloufar Kavian
1HKU-Pasteur Research Pole, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China
10Faculté de Médecine Université Paris Descartes, Sorbonne Paris Cité, Assistance Publique–Hôpitaux de Paris, Hôpital Universitaire Paris Centre, Centre Hospitalier Universitaire Cochin, Service d’Immunologie Biologique, Paris, France
11Institut Cochin, INSERM U1016, Université Paris Descartes, Sorbonne Paris Cité, Paris, France
Posted January 04, 2021.
The SARS-CoV-2 antibody landscape is lower in magnitude for structural proteins, diversified for accessory proteins and stable long-term in children
Asmaa Hachim, Haogao Gu, Otared Kavian, Mike YW Kwan, Wai-hung Chan, Yat Sun Yau, Susan S Chiu, Owen TY Tsang, David SC Hui, Fionn Ma, Eric HY Lau, Samuel MS Cheng, Leo LM Poon, JS Malik Peiris, Sophie A Valkenburg, Niloufar Kavian
medRxiv 2021.01.03.21249180; doi: https://doi.org/10.1101/2021.01.03.21249180
The SARS-CoV-2 antibody landscape is lower in magnitude for structural proteins, diversified for accessory proteins and stable long-term in children
Asmaa Hachim, Haogao Gu, Otared Kavian, Mike YW Kwan, Wai-hung Chan, Yat Sun Yau, Susan S Chiu, Owen TY Tsang, David SC Hui, Fionn Ma, Eric HY Lau, Samuel MS Cheng, Leo LM Poon, JS Malik Peiris, Sophie A Valkenburg, Niloufar Kavian
medRxiv 2021.01.03.21249180; doi: https://doi.org/10.1101/2021.01.03.21249180
Subject Area
Subject Areas
- Addiction Medicine (313)
- Allergy and Immunology (616)
- Anesthesia (158)
- Cardiovascular Medicine (2257)
- Dermatology (201)
- Emergency Medicine (368)
- Epidemiology (11549)
- Forensic Medicine (10)
- Gastroenterology (676)
- Genetic and Genomic Medicine (3541)
- Geriatric Medicine (336)
- Health Economics (612)
- Health Informatics (2287)
- Health Policy (910)
- Hematology (333)
- HIV/AIDS (742)
- Medical Education (357)
- Medical Ethics (100)
- Nephrology (385)
- Neurology (3326)
- Nursing (190)
- Nutrition (504)
- Oncology (1748)
- Ophthalmology (522)
- Orthopedics (208)
- Otolaryngology (283)
- Pain Medicine (222)
- Palliative Medicine (66)
- Pathology (435)
- Pediatrics (998)
- Primary Care Research (399)
- Public and Global Health (5974)
- Radiology and Imaging (1216)
- Respiratory Medicine (807)
- Rheumatology (367)
- Sports Medicine (311)
- Surgery (383)
- Toxicology (50)
- Transplantation (170)
- Urology (142)